You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The test runs on the firm's m2000 PCR platform and is the first on the market to assess resistance to both rifampin and isoniazid.
Genome sequencing is a new tool in the fight against drug-resistant bacteria, writes Lara Marks at The Conversation.
The funding comes as part of the agency's Advanced Molecular Detection initiative, which is using the technologies to help address infectious disease outbreaks.
In PLOS this week: mitochondrial DNA dynamics, tuberculosis transmission patterns in Malawi, and more.
The project aims to use omics and systems biology approaches to characterize strains of tuberculosis with an eye toward identifying therapeutic targets.
Researchers have identified mutations in the RORC gene that produce inborn errors of immunity affecting both interleukin-17 and interferon-gamma immune pathways.
In PNAS this week: human cytomegalovirus diversity, patterns of homologous recombination in E. coli, and more.
Intended for diagnosing active pulmonary tuberculosis, the test will use Cere's Nanotrap reagents for enriching target analytes for downstream analysis.
In PLOS this week: genomic analysis of Malaysian tuberculosis strain, database of bat genomes, and more.
Researchers combined genome sequences and drug susceptibility data for thousands of Mycobacterium tuberculosis isolates to find mutations for predicting resistance.
Los Angeles brought and settled a civil enforcement action against the makers of an at-home test for SARS-CoV-2, NPR reports.
The Guardian reports that Cancer Research UK is cutting its research funding by £44 million.
Technology Review examines factors affecting SARS-CoV-2 testing turnaround times.
In PNAS this week: mapping of ancient human migrations in Europe, recurrent gene fusion in breast cancer, and more.